Instylla, Inc., a developer of solutions for peripheral vascular embolotherapy, announced the FDA 510(k) clearance of the ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...

The Chinese General Hospital and Medical Center (CGHMC) successfully performed a transhepatic stent-assisted portal vein aneurysm coil embolization, ...

Instylla's Tembo system is a bioresorbable embolization agent designed for embolization of hypervascular tumors and blood ...